S2B), and patients with different induction regimens (though the IMid induction subgroup was excluded due to lack of statistical significance, it still exhibited a clear trend toward high-risk patients being more prone to sEMD), indicating its broad applicability in clinical practice (Additional file 1: Fig.
← all excerpts
Exploring secondary extramedullary myeloma disease: a five-predictor scoring system with spotlight on double-hit cytogenetics.
1
—
—